Baxter International Inc. (NYSE: BAX): Current price $70.09
On Friday, Baxter announced that it has successfully finalized its purchase of the privately held Gambro AB, a world medical tech firm and developer of dialysis products based in Lund, Sweden. The transaction further reinforces Baxter’s global renal leadership and gives the firm with a comprehensive product and therapies repertoire through which to address the requirements of patients in the large and growing dialysis market. The aggregate cash consideration for the transaction was roughly $3.9 billion. The effects of the acquisition were included in Baxter’s third quarter and full-year 2013 guidance.
Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.